# To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis

> **NCT06668506** · — · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 2814 (actual)

## Conditions studied

- Gastritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06668506
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-17
- **Primary completion:** 2022-11-03
- **Final completion:** 2024-03-13
- **Target enrollment:** 2814 (ACTUAL)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06668506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06668506, "To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06668506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*